Allozymes: Funding, Investors & Team (Oct 2026)
Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzyme development to the next level.
Allozymes has raised $5.0M across 1 funding round on record, the most recent a Seed of $5.0M announced in Jul 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Allozymes Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Allozymes Funding Rounds
Allozymes Founders and Leadership Team
Contact details for the Allozymes team: 1 of 1 has an email address on file.
Start 14-day free trial →Allozymes Funding Compared to Other Biotechnology Startups
Allozymes' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Allozymes in Biotechnology and Singapore
Companies Similar to Allozymes
YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…
Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…
ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…
Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…
Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…
BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…
Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in…
GDMC is a pharmaceutical organization that specializes in the production and development of genetic…
Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…
Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…
Allozymes Funding FAQs
What does Allozymes do?
Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzyme development to the next level.
How much funding has Allozymes raised?
Allozymes has raised $5.0M across 1 round on record. The most recent is a Seed of $5.0M announced in Jul 2021.
When did Allozymes last raise funding?
Allozymes' most recent funding round on record is a Seed of $5.0M, announced in Jul 2021.
Who is the CEO of Allozymes?
Peyman Salehian is listed as CEO at Allozymes.
Where is Allozymes headquartered?
Allozymes is based in Singapore, Central Region, Singapore.
How many employees does Allozymes have?
Allozymes is in the 1-10 employee band.
How does Allozymes' funding compare to other Biotechnology startups?
Allozymes' latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Allozymes Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Allozymes is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.